anti-hIAPP oligomer antibodies (Tel Aviv University)

N/A

Report date: 2025/01/26 19:06:27

Base Information

Drug Nameanti-hIAPP oligomer antibodies (Tel Aviv University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAmylin Receptor inhibitorsIslet amyloid polypeptide inhibitors
TargetsAmylin ReceptorIslet amyloid polypeptide
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTel Aviv University
China Registration ClassN/A

Develop Information

Active CompaniesRamot At Tel Aviv UniversityTel Aviv University
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A